http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220162332-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f463800b189460d162f06e1c045231c1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8aeaf0b8b8b64f684f0c5d7e913c9a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00865b46c752399b5080e18ba11afec1
publicationDate 2022-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20220162332-A
titleOfInvention Pharmaceutical sustained-release composition containing varenicline or pharmaceutically acceptable salts thereof as an active ingredient
abstract The present invention relates to a pharmaceutical sustained-release composition containing varenicline or a pharmaceutically acceptable salt thereof. Specifically, the present invention relates to a sustained-release agent and a pharmaceutically acceptable salt thereof for sustained release of varenicline or a pharmaceutically acceptable salt thereof. It relates to a pharmaceutical sustained-release composition capable of exhibiting stable sustained-release properties by combining a polymer for maintaining a sustained-release gel.
priorityDate 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24846132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454668499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5310966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71307060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452834898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426120401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6850753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448489261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452902523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260513

Total number of triples: 53.